Profile data is unavailable for this security.
About the company
SHANDONG PHARMACEUTICAL GLASS CO., LTD is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical glass products. The Company's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The Company distributes its products in domestic and overseas markets.
- Revenue in CNY (TTM)5.13bn
- Net income in CNY882.00m
- Incorporated1993
- Employees6.47k
- LocationShandong Pharmaceutical Glass Co LtdYiyuan CountyZIBO 256100ChinaCHN
- Phone+86 5 333259028
- Fax+86 5 333249700
- Websitehttp://www.pharmglass.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Zijiang Enterprise Group Co Ltd | 8.97bn | 636.15m | 11.45bn | 6.94k | 18.00 | 1.95 | -- | 1.28 | 0.4194 | 0.4194 | 5.91 | 3.88 | 0.6621 | 2.90 | 4.47 | 1,293,190.00 | 5.00 | 5.17 | 9.18 | 9.10 | 20.59 | 20.74 | 7.55 | 6.55 | 0.794 | 25.22 | 0.3783 | 65.58 | -5.13 | 0.2334 | -7.24 | 5.27 | 25.30 | 10.76 |
| Shandong Pharmaceutical Glass Co Ltd | 5.13bn | 882.00m | 16.85bn | 6.47k | 19.10 | 2.16 | -- | 3.28 | 1.33 | 1.33 | 7.74 | 11.74 | 0.5404 | 3.10 | 5.22 | 793,048.30 | 9.29 | 9.13 | 11.51 | 11.77 | 29.89 | 29.79 | 17.18 | 15.46 | 2.28 | -- | 0.08 | 32.56 | 18.98 | 14.03 | 25.48 | 16.71 | 14.09 | 13.30 |
Data as of Sep 13 2024. Currency figures normalised to Shandong Pharmaceutical Glass Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
13.68%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price International Ltd.as of 30 Sep 2024 | 17.99m | 2.71% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Sep 2023 | 17.01m | 2.56% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 24 May 2023 | 9.56m | 1.44% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 7.68m | 1.16% |
| Caitong Fund Management Co., Ltd.as of 24 May 2023 | 7.43m | 1.12% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2024 | 7.37m | 1.11% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2024 | 6.38m | 0.96% |
| GF Fund Management Co., Ltd.as of 30 Sep 2023 | 6.23m | 0.94% |
| Harvest Fund Management Co., Ltd.as of 30 Sep 2023 | 5.64m | 0.85% |
| Abu Dhabi Investment Authority (Investment Management)as of 30 Sep 2023 | 5.50m | 0.83% |
More ▼
Data from 30 Jun 2024 - 01 Nov 2024Source: FactSet Research Systems Inc.
